CMP vs GSK · rev $1.12B vs P/E 13, $103.31B cap
Compass Minerals International Inc (CMP) versus GlaxoSmithKline PLC ADR (GSK) — a side-by-side from cached financials, not a winner call.
Compass Minerals International Inc (CMP) is a other industrial metals & mining company listed on US.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
Latest reported CMP revenue for 2024-09-30 was $1.12B. Net income was -$206.1M. Revenue was down 7.2% from 2023-09-30 to 2024-09-30. CMP currently screens at market cap $916.5M.
GSK does not have a complete income-statement cache yet.
CMP currently screens at market cap $916.5M. GSK currently screens at market cap $103.31B and trailing P/E 13.5.
Not investment advice. Open the CMP and GSK stock pages for the full models.
Not investment advice.